Specifically, CDDP prompted the activation of the Nrf2/xCT pathway in NCI-H1299 and A549 lung cancer cell lines, with the activation level of this pathway correlates with the degree of CDDP resistance. This evidence concerns the gene NFE2L2 and lung cancer.